Standard Therapy for Anal Cancer May Not Affect Long-term Outcomes Among HIV Patients
Healthy HIV-positive patients with anal cancer are treated with standard chemoradiotherapy, but whether this patient population experiences worse outcomes or more severe toxic effects was previously unknown.